Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patientsLiangliang Wu, Huafeng Wei|Oncotarget|2017Cited by 110
Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibodyXiaojie Yu, Bohua Li, Bo Zhou et al.|Molecular Immunology|2017Cited by 23
Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibodyChao Wang, Bohua Li, Lingfei Wang et al.|Oncotarget|2017Cited by 21
Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinomaWei Chen, Huafeng Wei|Oncology Reports|2020Cited by 10